US BANCORP \DE\ - DICERNA PHARMACEUTICALS INC ownership

DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 146 filers reported holding DICERNA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 3.99 and the average weighting 0.4%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of DICERNA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$71,000
-90.9%
3,559
-82.9%
0.00%
-100.0%
Q2 2021$779,000
+58.3%
20,870
+8.5%
0.00%0.0%
Q1 2021$492,000
+15.0%
19,234
-1.1%
0.00%0.0%
Q4 2020$428,000
+38.5%
19,448
+13.1%
0.00%0.0%
Q3 2020$309,000
+202.9%
17,194
+326.1%
0.00%
Q2 2020$102,000
+85.5%
4,035
+35.6%
0.00%
Q1 2020$55,000
+103.7%
2,975
+147.9%
0.00%
Q4 2019$27,0001,2000.00%
Other shareholders
DICERNA PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 1,705,392$43,607,0007.88%
Bain Capital Life Sciences Investors, LLC 3,080,237$78,762,0004.46%
DAFNA Capital Management LLC 587,756$15,029,0003.57%
RTW INVESTMENTS, LP 7,463,291$190,836,0002.98%
SILVERARC CAPITAL MANAGEMENT, LLC 200,000$5,114,0002.79%
Evolutionary Tree Capital Management, LLC 122,473$3,132,0001.85%
Parkman Healthcare Partners LLC 303,268$7,755,0001.80%
Eagle Health Investments LP 161,125$4,120,0001.62%
BRIDGER MANAGEMENT, LLC 588,910$15,058,0001.41%
Woodline Partners LP 1,777,000$45,438,0001.01%
View complete list of DICERNA PHARMACEUTICALS INC shareholders